You are here: Industry Insights > GAVI

News List

Gavi collaborates with Salesforce for Covid-19 vaccine distribution pharmaceutical-technology
December 17, 2020
Gavi, the Vaccine Alliance, has collaborated with Cloud-based software company Salesforce to help the former in handling critical information to fairly distribute two billion Covid-19 vaccines to 190 countries by the end of next year.
Boost for global response to COVID-19 as economies worldwide formally sign up to COVAX facility worldpharmanews
September 22, 2020
64 higher income economies have joined the COVAX Facility, a global initiative that brings together governments and manufacturers to ensure eventual COVID-19 vaccines reach those in greatest need, whoever they are and wherever they live.
SII, Gavi and BMGF collaborate for COVID-19 vaccines, SII to price per vaccine dose at Rs 225 expresspharma
August 10, 2020
Serum Institute of India to produce up to 100 million COVID-19 vaccine doses which will be made available to the 92 countries included in Gavi’s COVAX Advance Market Commitment.
GAVI’s new drive for COVID-19 vaccine access in LMIC countries includes India expresspharma
August 03, 2020
The list of 92 AMC-eligible economies includes all economies with GNI per capita under $4,000 plus other World Bank International Development Association eligible economies.
Gavi announces 75 countries intend to join COVAX access facility pharmaceutical-technology
July 17, 2020
Gavi, The Vaccine Alliance, has said that 75 countries have expressed interest to join the COVAX access facility intended to ensure fast and equitable access to Covid-19 vaccines globally.
AZ ramps up supply capacity for COVID-19 vaccine pharmatimes
June 08, 2020
AstraZeneca has sealed landmark agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the Serum Institute of India (SII) to broaden global access to the University of Oxford’s COVID-19 vaccine.
AstraZeneca signs $750m Covid-19 vaccine manufacturing deal pharmaceutical-technology
June 08, 2020
straZeneca has signed a $750m agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi the Vaccine Alliance for the production, procurement and distribution of 300 million doses of the University of Oxford’s Covid-19 vaccine.
Bill & Melinda Gates Foundation pledges $1.6 billion to Gavi expresspharma
June 05, 2020
Funding secured for Gavi’s next strategic period will help the Alliance reach an additional 300 million children in the world’s most vulnerable communities and save up to eight million lives.
Gavi to award $75 million to Serum Institute of India for introduction of the pneumonia vaccine in d expresspharma
June 05, 2020
Until now, the only two producers of the pneumonia vaccine have been Pfizer and GlaxoSmithKline (GSK).
Gavi Vaccine Alliance seeks $7. 4bn to immunise 300 million people pharmaceutical-technology
September 03, 2019
Gavi, the Vaccine Alliance has initiated a $7.4bn fundraising drive to support the immunisation of 300 million children against 18 diseases, which could save up to eight million lives from 2021-25.

Previous page 1 2 3 4 Next page